|
 |
tegaserod maleateThis page contains recent news articles, when available, and an overview of tegaserod maleate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: tegaserod maleate (when available) Tegaserod is indicated for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation. Irritable bowel syndrome with constipation and chronic idiopathic constipation are both lower gastrointestinal dysmotility disorders. Clinical investigations have shown that both motor and sensory functions of the gut appear to be altered in patients suffering from irritable bowel syndrome (IBS), while in patients with chronic idiopathic constipation, reduced intestinal motility is the predominant cause of the condition. Both the enteric nervous system, which acts to integrate and process information in the gut, and 5-hydroxytryptamine (5-HT, serotonin) are thought to represent key elements in the etiology of both IBS and idiopathic constipation. Approximately 95% of serotonin is found throughout the gastrointestinal tract, primarily stored in enterochromaffin cells but also in enteric nerves acting as a neurotransmitter. Serotonin has been shown to be involved in regulating motility, visceral sensitivity and intestinal secretion. Investigations suggest an important role of serotonin Type-4 (5-HT4) receptors in the maintenance of gastrointestinal functions in humans. 5-HT4 receptor mRNA has been found throughout the human gastrointestinal tract. Provides relief from the symptoms of irritable bowel syndrome including chronic idiopathic constipation. Mechanism Of Action: Tegaserod is a 5-HT4 receptor partial agonist that binds with high affinity at human 5-HT4 receptors, whereas it has no appreciable affinity for 5-HT3 or dopamine receptors. It has moderate affinity for 5-HT1 receptors. Tegaserod, by acting as an agonist at neuronal 5-HT4 receptors, triggers the release of further neurotransmitters such as calcitonin gene-related peptide from sensory neurons. The activation of 5-HT4 receptors in the gastrointestinal tract stimulates the peristaltic reflex and intestinal secretion, as well as inhibits visceral sensitivity. News Articles on Tegaserod Alert Center: Tegaserod Maleate: Public Health Advisory - Mar 30, 2007 On March 30, 2007, Novartis, in compliance with an FDA request, suspended marketing and sales of its irritable bowel/constipation drug tegaserod maleate ... Medscape New Data for Tegaserod maleate Demonstrate Relief of Multiple … - Oct 24, 2006 LAS VEGAS, NV -- October 24, 2006 -- Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type dyspepsia, ... DG News Tegaserod Maleate Restricted to Emergency Use Only - Apr 4, 2008 April 4, 2008 — Tegaserod maleate (Zelnorm; Novartis) will only be available for emergency situations that are immediately life-threatening or serious ... Medscape Press Release: Novartis suspends US marketing and sales of Zelnorm(R)... - Apr 2, 2007 Novartis markets the therapy under the trademark Zelnorm (tegaserod maleate) in the US, Canada, Philippines and South Africa; and as Zelmac (tegaserod) in ... FierceBiotech Novartis drug roll-back may plague Cipla, Emcure - Apr 6, 2007 The NPAC is yet to take a view on tegaserod maleate. NPAC sources said that the panel is not yet aware of the US developments. ... Business Standard Press Release: Results Show Promise for Zelnorm in the Treatment of … - May 18, 2005 A new health economic study for Zelnorm(R) (tegaserod maleate) shows a significant ... Pharmacology & Therapeutics demonstrate Zelnorm (tegaserod maleate) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Significant increased risk of heart attack and stroke ... - Nov 3, 2008 A new health economic study for Zelnorm(R) (tegaserod maleate) shows a significant ... Pharmacology & Therapeutics demonstrate Zelnorm (tegaserod maleate) ... Pay-Per-View - PR Newswire - HighBeam Research Zelnorm Linked to Increased CV Events - Mar 30, 2007 It also noted that no effect of tegaserod maleate on the coronary arteries was seen in preclinical and clinical testing. Quoted in a company press release ... Medscape Press Release: Zelnorm(R) to be Made Available to US Patients Under … - Jul 27, 2007 A new health economic study for Zelnorm(R) (tegaserod maleate) shows a significant ... Pharmacology & Therapeutics demonstrate Zelnorm (tegaserod maleate) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Study Reveals Zelnorm(R) May Be a Safe and Effective … - May 22, 2006 LOS ANGELES, May 22 /PRNewswire/ -- Novartis today announced study results showing promise for Zelnorm(R) (tegaserod maleate) as a safe and efficacious ... Pay-Per-View - PR Newswire - HighBeam Research Irritable Bowel Syndrome (IBS) - Dec 16, 2005 Tegaserod maleate (Zelnorm®) is approved for women with IBS who have constipation as their main symptom. There aren't any conclusive diagnostic tests for ... WSOCtv.com Article: FDA to allow tegaserod use in certain patients.(Gastroenterol... - Aug 15, 2007 IBS The Novartis drug Zelnorm(TM) (tegaserod maleate ... Drug Administration (FDA) for the short-term ... Medicine in Dallas. "Zelnorm is an important ... Pay-Per-View - Internal Medicine News - HighBeam Research New Zelnorm® Data Demonstrate Relief Of Multiple Symptoms Of … - Nov 3, 2006 The gastrointestinal medicine Zelnorm® (tegaserod maleate) has demonstrated potential benefits in helping patients with the multiple symptoms of a common ... Medical News Today - Medical News Today (press release) FDA Announces Restricted Access Program for Zelnorm - Jul 27, 2007 July 27, 2007 — Restricted use of tegaserod maleate (Zelnorm, ... Although tegaserod maleate was suspended from the US market in March, when a safety ... Medscape Press Release: FDA Permits Restricted Use of Zelnorm for Qualifying … - Jul 27, 2007 The U.S. Food and Drug Administration announced that it is permitting the restricted use of Zelnorm (tegaserod maleate) under a treatment investigational ... Pay-Per-View - M2 Presswire - HighBeam Research Article: Unsafe IBS drugs back on the market.(Prescription for... - Sep 1, 2007 FDA Consumer; July 1, 2004 ; 610 words ... ... taking or prescribing Zelnorm (tegaserod maleate ... FDA has revised the drug's labeling to include ... for ... Pay-Per-View - Women's Health Activist - HighBeam Research Zelnorm effective against common dsypepsia. - Oct 30, 2006 Swiss drug major Novartis says that its gastrointestinal medicine Zelnorm (tegaserod maleate) demonstrated potential benefits in helping patients with the ... $9.94 - Pharma Marketletter - Alacra Store St. Paul Pioneer Press (MN) - Mar 31, 2007 Zelnorm, also called tegaserod maleate, is a prescription medication approved for short-term treatment of women with irritable bowel syndrome with ... $2.95 - St. Paul Pioneer Press - NewsBank Study Reveals Zelnorm(R) May Be A Safe And Effective Treatment For … - May 23, 2006 Novartis today announced study results showing promise for Zelnorm(R) (tegaserod maleate) as a safe and efficacious medical treatment for patients with ... Medical News Today - Medical News Today (press release) FDA CAPSULES - Aug 7, 2007 The U.S. Food and Drug Administration is permitting the restricted use of Zelnorm (tegaserod maleate) under an investigational protocol to treat irritable ... Pay-Per-View - Newsday - ProQuest Archiver Article: Tegaserod for IBS in women.(CLINICAL CAPSULES)(Brief... - Dec 15, 2005 Formulary; September 1, 2002 ; 700+ words ... ... constipationpredominant irritable bowel syndrome Abstract Tegaserod maleate (Zelnorm), an aminoguanidine ... Pay-Per-View - Internal Medicine News - HighBeam Research Implants and suicide link - Aug 22, 2008 In compliance with an US-FDA request, Novartis has suspended marketing and sales of its irritable bowel/constipation drug Zelnorm (tegaserod maleate) which ... News Today Online Novartis Committed To Making Zelnorm(R) Available For Women With … - Dec 17, 2005 ...including the United States, Canada and Mexico. Novartis markets Zelnorm (tegaserod maleate) in the US, Canada, Philippines and South Africa; and under the. Medical News Today - Medical News Today (press release) Pilot Study on the Effect of Linaclotide in Patients With Chronic … - Jan 9, 2008 Tegaserod maleate (marketed as Zelnorm) March 30, 2007. Amitiza (lubiprostone) Prescribing Information. Sucampo Pharmaceuticals Inc. February, 2006. ... Nature.com New Developments in the Treatment of Constipation: Editor's Note - Jan 11, 2005 On March 30, 2007, Novartis, in compliance with an FDA request, suspended marketing and sales of its irritable bowel/constipation drug tegaserod maleate ... Medscape Tegaserod for Female Patients Suffering From IBS With Mixed Bowel … - Mar 8, 2007 ...announced itwould comply with a request from the Food and Drug Administration (FDA) to suspend US marketing and sales of tegaserod maleate (Zelnorm). ... Nature.com Does Sex Make a Difference? - Jul 19, 2005 For example, Zelnorm (tegaserod maleate) is approved only for women to relieve the symptoms of IBS. In clinical trials, more women taking Zelnorm reported ... RedOrbit Novartis' Zelnorm "safe and efficacious" in IBS. - May 29, 2006 Swiss drug major Novartis says that new study results, which show its serotonin receptor antagonist Zelnorm (tegaserod maleate) is a "safe and efficacious" ... Free with registration - Pharma Marketletter - AccessMyLibrary.com US drug DTC cuts in 1st-half 2008: TV ad effectiveness low, regulatory... - Oct 27, 2008 ...and Schering-Plough, respectively, and Zelnorm (tegaserod maleate), an irritable-bowel-syndrome treatment from Swiss pharmaceutical major Novartis. ... $9.94 - Pharma Marketletter - Alacra Store Zelnorm® May Be Safe and Effective for Some IBS Patients With Mixed … - Jun 8, 2006 LOS ANGELES -- Novartis announced study results showing promise for Zelnorm® (tegaserod maleate) as a safe and efficacious medical treatment for patients ... EndoNurse Relief for Constipation; 'Zelnorm Works By Increasing the Contraction... - Nov 3, 2005 The drug, Zelnorm (tegaserod maleate) is the first and only FDA- approved medicine for the treatment of chronic constipation that lasts for more than six ... RedOrbit Article: Constipation Drug Pulled Upon FDA's Request - The Washington... - Mar 31, 2007 Zelnorm, also called tegaserod maleate, is a prescription medication approved for the short-term treatment of women with irritable bowel syndrome, ... Pay-Per-View - Washington Post - HighBeam Research Novartis' 4th-qtr profits fall 45%; but full-year 2007 income climbs... - Jan 21, 2008 ...given the withdrawal of the bowel disease drug Zelnorm (tegaserod maleate; Marketletter August 6, 2007) and the impact of generic competition for key ... $9.94 - Pharma Marketletter - Alacra Store Zelnorm[R].(POSTSCRIPTS)(Brief article) - Mar 22, 2006 ZELNORM[R] (tegaserod maleate, Novartis) is a prescription medication that the FDA had approved in 2002 for the short-term treatment of women with irritable ... Free with registration - Nutrition Health Review - AccessMyLibrary.com Novartis breaks ground on Singapore facility - Mar 8, 2005 ...pressure drug Diovan (valsartan) and cancer treatment Glivec (imatinib), as well as its irritable bowel symdrome treatment Zelnorm (tegaserod maleate). ... In-PharmaTechnologist.com Two drugs withdrawn at FDA behest - Mar 30, 2007 Tegaserod maleate (Zelnorm) and pergolide (Permax and generics) have been withdrawn from the market for safety concerns. Tagaserod had been approved for ... Cortlandt Forum Competitors by Product Report - Mar 29, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere Reports - Revere Antibiotic proves promising - Jan 4, 2006 Researchers are now testing the use of another drug, tegaserod maleate, can help prevent overgrowth of bacteria for longer periods of time. WOWT Antidepressants often better than bulking agents for IBS.(News)(irrita... - May 1, 2005 In clinical trials, tegaserod maleate (Zelnorm) was effective in about 40% of patients. Yet about 30% of placebo patients had improvement, as they often do ... Free with registration - Internal Medicine News - AccessMyLibrary.com US Public Citizen "told you so" about Zelnorm.(Brief article) - Apr 9, 2007 Drug Administration in 2001, of Switzerland-based drug major Novartis' constipation-predominant diarrhea drug Zelnorm (tegaserod maleate; see page 3). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Extensive work-up rarely needed to diagnose IBS.(Gastroenterology)( … - Dec 15, 2008 ...at an international ... welcome, given the scarcity of approved agents for irritable bowel syndrome (IBS), particularly since tegaserod maleate ... ... Pay-Per-View - Internal Medicine News - HighBeam Research Delayed Gastric Emptying Doesn't Affect Quality of Life Dyspeptic... - Nov 17, 2006 On March 30, 2007, Novartis, in compliance with an FDA request, suspended marketing and sales of its irritable bowel/constipation drug tegaserod maleate ... Medscape Non-GI symptoms can help differentiate bowel disorders.(Clinical... - Dec 1, 2005 They should have read, "Tegaserod maleate (Zelnorm), approved in 2002, is indicated for IBS patients with constipation. Alosetron hydrochloride (Lotronex) ... Pay-Per-View - OB GYN News - HighBeam Research Suspended – sale of drug to treat IBS - Apr 3, 2007 The medication Zelmac (tegaserod maleate), which is marketed in the United States under the brand name Zelnorm, has been found by the Food and Drug ... Malaysia Star Competitors by Product Report - Mar 1, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere Reports - Revere Irritable Bowel Syndrome: New and Emerging Therapies - Mar 3, 2006 On March 30, 2007, Novartis, in compliance with an FDA request, suspended marketing and sales of its irritable bowel/constipation drug tegaserod maleate ... Medscape national/new jerey state briefs - Mar 31, 2007 Zelnorm, also called tegaserod maleate, is a prescription medication approved for short-term treatment of women with irritable bowel syndrome with ... $2.95 - Press of Atlantic City, The - NewsBank DTC effectiveness doubted as drugmakers are accused of exploiting … - Sep 8, 2008 ...majors Wyeth and Schering-Plough, respectively, and Zelnorm (tegaserod maleate), an irritable-bowel treatment from Swiss pharmaceutical major Novartis. ... $9.94 - Pharma Marketletter - Alacra Store tegaserod Novartis submitted for approval, Europe (irritable bowel … - Feb 7, 2005 ...tegaserod, tegaserod maleate, HTF 919, SDZ HTF919, SDZ-HTF 919, ZELMAC, ZELNORM, IRBEZ, TAGON, TAGESPA, TEGIBS, TEGASER, IBSINORM, TIBS-6, TEGASPA, A3G, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Review Article: Intestinal Serotonin Signalling in IBS: Editor's Note - Apr 13, 2006 On March 30, 2007, Novartis, in compliance with an FDA request, suspended marketing and sales of its irritable bowel/constipation drug tegaserod maleate ... Medscape Company agrees to halt sales of constipation drug - Mar 31, 2007 Novartis agreed to withdraw Zelnorm, also called tegaserod maleate, at the FDA's request, the agency said in a public-health advisory. Pay-Per-View - Orlando Sentinel - ProQuest Archiver BRIEFS - Mar 31, 2007 Also called tegaserod maleate, the prescription medication is approved for short-term treatment of women with irritable bowel syndrome with constipation and ... Pay-Per-View - Newsday - ProQuest Archiver Competitors by Product Report - Jun 21, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere - Alacra Store AbelsonTaylor Expands DTC Capabilities. - Nov 27, 2006 ...of the most successful Rx consumer launches in history, including the Gold Effie Award-winning campaign for Zelnorm (tegaserod maleate) from Novartis. ... Free with registration - PR Newswire - AccessMyLibrary.com Irritable Bowel Syndrome; Study of pro-motility agent shows improved ... - Jan 24, 2005 2005 JAN 24 - (NewsRx.com & NewsRx.net) -- A new health economic study for Zelnorm (tegaserod maleate) shows a significant improvement in overall work ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Competitors by Product Report - Jun 21, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere Reports - Revere Millions Live With Painful GI Symptoms Impacting Their Lives, But … - Oct 5, 2006 Novartis Pharmaceuticals Corporation, manufacturer of Zelnorm(R) (tegaserod maleate), is the exclusive sponsor of the ABCs of GI Relief Health Center at ... Medical News Today - Medical News Today (press release) Irritable Bowel Syndrome; Study of pro-motility agent shows improved ... - Jan 25, 2005 2005 JAN 25 - (NewsRx.com & NewsRx.net) -- A new health economic study for Zelnorm (tegaserod maleate) shows a significant improvement in overall work ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Competitors by Product Report - Jun 21, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere Reports - Revere Restricted Zelnorm Use Permitted - Jul 31, 2007 The FDA is permitting restricted Zelnorm (tegaserod maleate) use under investigational new drug (IND) protocol to treat irritable bowel syndrome with ... Facts and Comparisons News in brief - April 23/30, 2007 - Apr 23, 2007 At the request of the Food and Drug Administration, Novartis Pharmaceuticals has stopped marketing Zelnorm (tegaserod maleate) because of an increased risk ... American Medical News Zelnorm pulled off the shelf due to possible cardiovascular risk... - Apr 15, 2007 Novartis has agreed tO withdraw its irritable bowel syndrome drug Zelnorm (tegaserod maleate) from the US market in response to a Food and Drug ... Free with registration - Family Practice News - AccessMyLibrary.com Life Science News Briefs Vol. 7 no.5 — April 5 2007 - Apr 5, 2007 Novartis Canada (Dorval) is complying with a request from Health Canada to suspend Canadian marketing and sales of Zelnorm(R)(1) (tegaserod maleate) as a ... ic.gc.ca Novartis' sales up 17% to $7.2 B in 2006, with eight product launches... - Jan 29, 2007 Revenue gains were also made by: the breast cancer drug Femara (letrozole), up 33% to $719.0 million; Zelnorm/ Zelmac (tegaserod maleate) for the treatment ... Free with registration - Pharma Marketletter - AccessMyLibrary.com AbelsonTaylor, the largest independent advertising agency in the … - Jan 1, 2007 ...of the most successful Rx consumer launches in history, including the Gold Effie Award-winning campaign for Zelnorm (tegaserod maleate) from Novartis. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com From the pharmacy.(MEDICAL MAILBOX) - Jul 1, 2007 IBS Drug Pulled From Shelves: The makers of Zelnorm (tegaserod maleate) have voluntarily discontinued sales of this drug. The reason: concerns over serious ... Free with registration - Saturday Evening Post - AccessMyLibrary.com Lawyers Seek FDA Zelnorm Documents through Freedom of Information … - Feb 20, 2007 USC 552) seeking documents and records as they pertain to the Novartis Pharmaceuticals Corporation's drug Zelnorm (tegaserod maleate). ... prleap.com Commercial interruptions: The hidden costs of drug ads - Apr 2, 2007 Kurt Stange, MD, PhD, professor of family medicine at Case Western Reserve University in Cleveland, found a Novartis ad for Zelnorm (tegaserod maleate), ... American Medical News MANAGE IBS WITHOUT SPECIAL DRUGS - Jun 28, 2007 Earlier this year, the Food and Drug Administration asked the company that makes tegaserod maleate (Zelnorm) to remove the drug from the market. ... $2.95 - Myrtle Beach Sun News - NewsBank Does sex make a difference? - Jul 1, 2005 For example, Zelnorm (tegaserod maleate) is approved only for women to relieve the symptoms of IBS. In clinical trials, more women taking Zelnorm reported ... $4.95 - FDA Consumer - ECNext Vaccines and diagnostics help Swiss major Novartis beat expectations. - Apr 28, 2008 ...competition for four products and the marketing suspension of its bowel disease therapy Zelnorm (tegaserod maleate; Marketletter August 6, 2007). ... $9.94 - Pharma Marketletter - Alacra Store Salix Pharmaceuticals Reports American College of Gastroenterology … - Oct 24, 2006 Patients had failed numerous therapies including PEG solution, tegaserod maleate and lactulose. Patients were treated with 1 (n=1), 2 (n=1) or 3 (n=7) ... Free with registration - Business Wire - AccessMyLibrary.com Press of Atlantic City, The (NJ) - Jul 28, 2007 The agency said it asked Swiss pharmaceutical maker Novartis AG in March to suspend sales of the prescription drug, also called tegaserod maleate, ... $2.95 - Press of Atlantic City, The - NewsBank Factiva Search - Jan 24, 2005 2005 JAN 24 - (NewsRx.com & NewsRx.net) -- A new health economic study for Zelnorm (tegaserod maleate) shows a significant ... ... Pay-Per-View - Managed Care Weekly Digest - Factiva, from Dow Jones Competitors by Product Report - Jun 21, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere - Alacra Store Rias A/S acquires Nordisk Plast A/S - Deal Snapshot - AlacraStore.com - Mar 3, 2008 Modulator) Zelnorm (Tegaserod Maleate) Novo Nordisk A/S (ADR) ( NVO ) Products: NovoSeven (Recombinant…Low Dose Paroxetine Mesylate) Novo Nordisk A/S (ADR) ... Pay-Per-View - deals - Alacra Store AbelsonTaylor, the largest independent advertising agency in the … - Jan 1, 2007 ...of the most successful Rx consumer launches in history, including the Gold Effie Award-winning campaign for Zelnorm (tegaserod maleate) from Novartis. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research CBT promising for treatment of irritable bowel syndrome.( … - Feb 15, 2008 Internal Medicine News; July 1, 2007 ; 700+ words ... ... approved agents for irritable bowel syndrome (IBS), particularly since tegaserod maleate ... said. ... Pay-Per-View - Internal Medicine News - HighBeam Research Competitors by Product Report - Jan 12, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere Reports - Revere Avoid bulking agents in diarrhea-predominant IBS.(Clinical Rounds) - May 15, 2005 In clinical trials, tegaserod maleate (Zelnorm) was effective in about 40% of patients. Yet, about 30% of placebo patients had improvement, as they often do ... Pay-Per-View - OB GYN News - Factiva, from Dow Jones Factiva Search - Jan 24, 2005 2005 JAN 24 - (NewsRx.com & NewsRx.net) -- A new health economic study for Zelnorm (tegaserod maleate) shows a significant ... ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones Antidepressants show promise for IBS treatment.(Gastroenterology)( … - Aug 15, 2008 Internal Medicine News; July 1, 2007 ; 700+ words ... ... approved agents for irritable bowel syndrome (IBS), particularly since tegaserod maleate ... said. ... Pay-Per-View - Internal Medicine News - HighBeam Research Irritable Bowel Syndrome; Study of pro-motility agent shows improved ... - Jan 28, 2005 2005 JAN 28 - (NewsRx.com & NewsRx.net) -- A new health economic study for Zelnorm (tegaserod maleate) shows a significant improvement in overall work ... Pay-Per-View - Drug Week - Factiva, from Dow Jones A spokesperson for the Food and Drug.(POSTSCRIPTS)(Brief article) | … - Dec 22, 2005 ZELNORM[R] (tegaserod maleate, Novartis) is a prescription medication that the F.D.A. had approved in 2002 for the short-term treatment of women with ... Pay-Per-View - Nutrition Health Review - HighBeam Research Article: IBS drug pipeline offers some promise.(Gastroenterology)(Irri... - Jul 1, 2007 New drugs would be welcome, given the scarcity of approved agents for irritable bowel syndrome (IBS), particularly since tegaserod maleate (Zelnorm) was ... Pay-Per-View - Internal Medicine News - HighBeam Research Competitors by Product Report - Dec 13, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere Reports - Revere Sales Halted for Constipation Drug | Article from AP Online |... - Mar 30, 2007 Zelnorm, also called tegaserod maleate, is a prescription medication approved for short-term treatment of women with irritable bowel syndrome with ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Harvard Women's Health Watch May , 2005 - May 1, 2005 A. Zelnorm (tegaserod maleate) is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary symptom ... $4.95 - Harvard Women's Health Watch - ECNext Zelnorm's potential for GI disorders revealed.(GastroIntestinal) - May 30, 2005 ...which took place in Chicago, Illinois, USA, indicate that Novartis' irritable bowel syndrome drug Zelnorm (tegaserod maleate) may offer a novel approach ... $4.95 - Pharma Marketletter - ECNext Dot-whacked.(Viewpoint) | Article from Medical Marketing & Media | … - May 1, 2007 Medical Marketing & Media; January 1, 2007 ; 700+ words ... ... campaign for Zelnorm (tegaserod maleate) from Novartis. He was also responsible for the ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Two nutritional scientists.(POSTSCRIPTS)(Brief article) | Article... - Dec 22, 2005 ZELNORM[R] (tegaserod maleate, Novartis) is a prescription medication that the F.D.A. had approved in 2002 for the short-term treatment of women with ... Pay-Per-View - Nutrition Health Review - HighBeam Research Zelnorm pulled off the shelf due to possible cardiovascular risk... - Apr 15, 2007 FDA) ... find Family Practice News articles. Novartis has agreed tO withdraw its irritable bowel syndrome drug Zelnorm (tegaserod maleate) from the US m... Pay-Per-View - Family Practice News - HighBeam Research Press Release: AbelsonTaylor Expands DTC Capabilities. - PR Newswire … - Nov 27, 2006 ...of the most successful Rx consumer launches in history, including the Gold Effie Award-winning campaign for Zelnorm (tegaserod maleate) from Novartis. ... Pay-Per-View - PR Newswire - HighBeam Research Competitors by Product Report - Oct 11, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere Reports - Revere IBS drug pipeline offers some promise to patients.(Clinical Rounds) - Jul 1, 2007 New drugs would be welcome, given the scarcity of approved agents for irritable bowel syndrome (IBS), particularly since tegaserod maleate (Zelnorm) was ... $4.95 - Skin & Allergy News - ECNext Competitors by Product Report - Dec 13, 2008 Novartis AG (ADR) (NVS) Products:. AKU517; Idenix Valtorcitabine/LDC300; NIM811 (Cyclophilin Binding HCV RdRP Modulator); Zelnorm (Tegaserod Maleate) ... $75.00 - Revere - Alacra Store Alizyme updates on Ph III R&D program in preparation for a busy... - Oct 15, 2007 The firm said that, since the withdrawal of Novartis' former market leading IBS medication Zelnorm (tegaserod maleate; Marketletter August 6), ... $4.95 - Pharma Marketletter - ECNext Narcotic bowel syndrome requires withdrawal.(Gastroenterology) |... - Jan 1, 2008 ...symposium ... welcome, given the scarcity of approved agents for irritable bowel syndrome (IBS), particularly since tegaserod maleate (Zelnorm ... ... Pay-Per-View - Internal Medicine News - HighBeam Research Zelnorm, pergolide off the market.(In Other News) - Jun 1, 2007 At the FDA's request, the manufacturers of the irritable bowel syndrome treatment Zelnorm (tegaserod maleate) and the Parkinson's disease drug pergolide ... $4.95 - Pharmaceutical Representative - ECNext Axcan Pharma appoints new Senior Vice President and Chief Scientific ... - May 10, 2006 While at Novartis, Dr. LeBeaut served as a project leader on major research programs, including the development of Zelnorm(R) (tegaserod maleate), ... $4.95 - PR Newswire - ECNext Brand Names/Synonyms: tegaserod maleate is also known by the following brand names and/or synonymsHTF 919; SDZ HTF 919; Tegaserod; Tegaserod Maleate; Tegaserod [Usan:Inn:Ban]; Zelmac; Zelnorm Drug Category: tegaserod maleate is categorized under the following by the FDA: Gastrointestinal Agents; ATC:A03AE02 Dosage Forms: TABLET Absorption: Rapidly absorbed after oral administration. Absolute bioavailability is approximately 10%. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: [3-[(amino-pentylimino-methyl)aminoiminomethyl]-1H-indol-5-yl]methanol |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |